Swarts SG, Rice L, Zhang BS, Zhang Z, Zhang A, 2Derendorf H, 2Chandasana H, 2Prasanchaimontri I-O, 1 Vidyasagar S, 1 Yin L, 1Casey-Sawicki K, Okunieff P Read more.
GainPep WebmasterApril 8, 2018
GainPep, Inc. is an early-stage drug development company.
Our research focuses on the powerful wound-healing drug candidate fibroblast growth factor-peptide (FGF-P) and its derivatives. This agent will allow for many marketing opportunities, ranging from biosecurity to basic research to bone marrow transplantation to tissue engineering.
”FGF-P has the potential to become the most effective and safest wound-healing drug on the market.
Paul OkunieffM.D.
Recent Publications and Presentations
Zhang L, Sun W, Wang J, Zhang M, Yang S, Tian Y, Vidyasagar S, Peña LA, Zhang K, Cao Y, Yin L, Wang W, Zhang…
GainPep WebmasterMarch 17, 2018
Zhang K, Tian Y, Yin L, Zhang M, Beck LA, Zhang B, Okunieff P, Zhang L, Vidyasagar S. Int J Radiat Oncol Biol Phys. 2011…
GainPep WebmasterMarch 17, 2018
Ma J, Hou Y, Han D, Zhang M, Chen C, Zhang B, Zhang Z, Wang X, Yang S, Guo Y, Okunieff P, Zhang L. Adv…
GainPep WebmasterMarch 17, 2018
Casey-Sawicki K, Zhang M, Kim S, Zhang A, Zhang SB, Zhang Z, Singh R, Yang S, Swarts S, Vidyasagar S, Zhang L, Zhang A, Okunieff…
GainPep WebmasterFebruary 27, 2018